bw 306u has been researched along with Depressive Disorder in 2 studies
hydroxybupropion: active metabolite of bupropion; structure in first source
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Alternatively, a curvilinear dose-response relationship may exist for bupropion metabolites." | 2.66 | Bupropion in depression. II. The role of metabolites in clinical outcome. ( De Vane, CL; Golden, RN; Laizure, SC; Potter, WZ; Rudorfer, MV; Sherer, MA, 1988) |
| "Bupropion is a dopamine and norepinephrine reuptake inhibitor approved for the treatment of depression and smoking cessation." | 1.40 | Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion. ( Brünen, S; Hiemke, C; Laib, AK; Pfeifer, P; Vincent, P, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laib, AK | 1 |
| Brünen, S | 1 |
| Pfeifer, P | 1 |
| Vincent, P | 1 |
| Hiemke, C | 1 |
| Golden, RN | 1 |
| De Vane, CL | 1 |
| Laizure, SC | 1 |
| Rudorfer, MV | 1 |
| Sherer, MA | 1 |
| Potter, WZ | 1 |
1 trial available for bw 306u and Depressive Disorder
| Article | Year |
|---|---|
Bupropion in depression. II. The role of metabolites in clinical outcome.
Topics: Adult; Aged; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; | 1988 |
1 other study available for bw 306u and Depressive Disorder
| Article | Year |
|---|---|
Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion.
Topics: Antidepressive Agents, Second-Generation; Area Under Curve; Bupropion; Chromatography, High Pressure | 2014 |